Point72 Asset Management »

Pmv Pharmaceuticals shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Pmv Pharmaceuticals (PMVP) shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Pmv Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Pmv Pharmaceuticals held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pmv Pharmaceuticals by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.3M 750k 3.10
2023-03-31 $182k 38k 4.77

More positions owned by Point72 Asset Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Meta Platforms Cl A (META)
Dell Technologies CL C (DELL)
Union Pacific Corporation (UNP)
Boston Scientific Corporation (BSX)
Johnson Ctls Intl SHS (JCI)
NVIDIA Corporation (NVDA)
FedEx Corporation (FDX)
Microsoft Corporation (MSFT)
CSX Corporation (CSX)
Honeywell International (HON)
Thermo Fisher Scientific (TMO)
Oracle Corporation (ORCL)
Western Digital (WDC)

View all positions for Point72 Asset Management

Top funds holding Pmv Pharmaceuticals

OrbiMed Advisors
Jpmorgan Chase & Co
Arrowpoint Asset Management
Euclidean Capital
Vanguard Group
Partner Fund Management
Bank of America Corporation
BML Capital Management
Citadel Advisors
Goldman Sachs Group
Point72 Asset Management
Federated Investors
Vontobel Holding
EcoR1 Capital
Dimensional Fund Advisors

View all funds holding Pmv Pharmaceuticals